ISPE’s official blog, iSpeak accepts contributions from our Members and professionals in the pharma industry.
The pharmaceutical industry is undergoing a technological revolution, driven by digital transformation and emerging technologies such as AI/machine learning (ML). These innovations are being applied across the entire product lifecycle from research and development and clinical development to manufacturing, quality assurance, supply chain, and patient support. A critical focus area is the...
Engineering compliance often operates silently in the background of pharmaceutical manufacturing, enabling good manufacturing practice (GMP) operations to run safely, reliably, and consistently. From maintaining plant utilities to managing a controlled clean room environment to documenting equipment and modifications, engineering compliance plays an important role in effective operations. As...
For decades, pharmaceutical companies have grappled with a frustrating reality: bringing a post-approval change to market globally could take up to seven, or in some cases more, years. That meant patients in some countries had to wait years longer than others to benefit from manufacturing improvements, new production sites, or process enhancements. But a shift is underway in the regulatory...
Why This ISPE Podcast Episode Is a Must Listen for Industry Innovators
Artificial intelligence (AI) continues to redefine how pharmaceutical companies develop products, ensure quality, and manage complex global operations.
In September 2024, Hurricane Helene, a category 4 hurricane, hit the Baxter North Cove facility in North Carolina, US, the largest manufacturer of intravenous and peritoneal dialysis products in the US. Through a close partnership with the US FDA, Baxter restarted eight of 10 manufacturing lines and began to function at close to 85 percent of normal capacity by December 2024.
Regulatory inspections place pharmaceutical quality and operations teams under intense scrutiny. Following the exit meeting, the issuance of observations triggers a demanding 15-day timeline (for US FDA Inspections) to deliver a complete and defensible response, frequently accompanied by significant stress, coordination challenges, and compliance risk.
The ISPE Nordic Affiliate Annual Meeting 2026, held at AstraZeneca’s Södertälje site in Sweden, brought together over 100 pharma leaders, regulators, and innovators - participants came from across the Nordic region and beyond.
Despite the mission-critical nature of validation processes, many life sciences companies use traditional validation methods that rely on paper-based processes or basic digital solutions. Manual, fragmented legacy approaches waste time and effort, increase risks, and slow down time to market.
In an industry where scientific advancement moves swiftly and regulatory expectations continue to expand, continuous learning has become essential. The International Society for Pharmaceutical Engineering (ISPE) supports this ongoing need with structured, practice-oriented education designed for real-world impact. Through the
Artificial intelligence is no longer confined to innovation labs within life sciences organizations. It is now influencing drug and device development, clinical research, manufacturing operations, supply chain performance, and post-market surveillance. AI systems are accelerating molecule screening, enhancing pharmacovigilance signal detection, optimizing maintenance programs, and supporting...
Explore two standout sessions from the 2025 ISPE Aseptic Conference that offer a glimpse into the valuable discussions shaping the 2026 ISPE Aseptic Conference. Featuring thought leaders across the industry, these sessions include “Industry Panel:...
In an era where agility, data-driven decision-making, and digital connectivity define manufacturing excellence, the Pharma 4.0™ in Action track at the 2026 ISPE Europe Annual Conference stands out as a must-attend content area for professionals seeking...
